JIP
RMD icon

Jaffetilchin Investment Partners’s ResMed RMD Stock Holding History

Jaffetilchin Investment Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-19,192
Closed -$866K – 192
2013
Q2 		$866K Buy
+19,192
New +$911K 0.6% 39

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LCG
Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Jaffetilchin Investment Partners's RMD Position: Q3 2013 in Review

Jaffetilchin Investment Partners sold out of ResMed (RMD) in Q3 2013, closing a stake of 19,192 shares — an estimated $866K sold.

Jaffetilchin Investment Partners first reported a position in RMD in Q2 2013 and held it in 1 quarter. The position peaked at $866K in Q2 2013. 322 funds tracked by Wall St. Rank hold RMD as of Q3 2013.

  • Jaffetilchin Investment Partners reported no remaining ResMed position as of Q3 2013 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 19,192 ResMed shares in Q3 2013, an estimated $866K.
  • Jaffetilchin Investment Partners first reported a position in ResMed in Q2 2013 and held it in 1 quarter.
  • Jaffetilchin Investment Partners's ResMed position peaked at $866K in Q2 2013.
  • 322 funds tracked by Wall St. Rank held ResMed as of Q3 2013.

Based on Jaffetilchin Investment Partners's 13F filing for Q3 2013, filed 8 Nov 2013.